339 related articles for article (PubMed ID: 36296904)
1. Associations between Healthy Lifestyle and All-Cause Mortality in Individuals with Metabolic Associated Fatty Liver Disease.
Wang X; Wang A; Zhang R; Cheng S; Pang Y
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36296904
[TBL] [Abstract][Full Text] [Related]
2. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population.
Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX
Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716
[TBL] [Abstract][Full Text] [Related]
3. Association between serum 25-hydroxy vitamin D concentrations and mortality among individuals with metabolic dysfunction-associated fatty liver disease: a prospective cohort study.
Zhang JJ; Yu HC; Li Y; Zhang YB; Geng TT; Lu Q; Liao YF; Guo KQ; Du L; Ruan HL; Yang K; Liu G; Pan A
Am J Clin Nutr; 2022 Nov; 116(5):1409-1417. PubMed ID: 36107812
[TBL] [Abstract][Full Text] [Related]
4. Adherence to healthy lifestyle was associated with an attenuation of the risk of chronic kidney disease from metabolic dysfunction-associated fatty liver disease: Results from two prospective cohorts.
Zhang Y; Zhang T; Liu Y; Bai S; Jiang J; Zhou H; Luan J; Cao L; Lv Y; Zhang Q; Liu L; Sun S; Wang X; Zhou M; Jia Q; Song K; Zhang H; Chang Q; Fan X; Ding Y; Chen L; Zhao Y; Niu K; Xia Y
Diabetes Metab Syndr; 2023 Oct; 17(10):102873. PubMed ID: 37804689
[TBL] [Abstract][Full Text] [Related]
5. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.
Kim D; Konyn P; Sandhu KK; Dennis BB; Cheung AC; Ahmed A
J Hepatol; 2021 Dec; 75(6):1284-1291. PubMed ID: 34380057
[TBL] [Abstract][Full Text] [Related]
6. Metabolic-associated fatty liver disease in relation to site-specific and multiple-site subclinical atherosclerosis.
Wang X; Zhang R; Man S; Lv J; Yu C; Yin J; Wang X; Deng Y; Wang B; Li L; Pang Y
Liver Int; 2023 Aug; 43(8):1691-1698. PubMed ID: 37337780
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis.
Muthiah M; Ng CH; Chan KE; Fu CE; Lim WH; Tan DJH; Nah B; Kong G; Xiao J; Yong JN; Tan B; Syn N; Wang JW; Sayed N; Tan E; Chew NW; Dan YY; Siddiqui MS; Sanyal AJ; Noureddin M
Ann Hepatol; 2023; 28(1):100762. PubMed ID: 36182031
[TBL] [Abstract][Full Text] [Related]
8. Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort.
Cheng WC; Chen HF; Cheng HC; Li CY
Epidemiol Health; 2024; 46():e2024024. PubMed ID: 38317531
[TBL] [Abstract][Full Text] [Related]
9. Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD.
Nguyen VH; Le MH; Cheung RC; Nguyen MH
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2172-2181.e6. PubMed ID: 34033923
[TBL] [Abstract][Full Text] [Related]
10. NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III.
Huang Q; Zou X; Wen X; Zhou X; Ji L
Front Med (Lausanne); 2021; 8():693507. PubMed ID: 34277667
[No Abstract] [Full Text] [Related]
11. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
12. Metabolic-associated fatty liver disease and the risk of cardiovascular disease.
Zhang P; Dong X; Zhang W; Wang S; Chen C; Tang J; You Y; Hu S; Zhang S; Wang C; Wen W; Zhou M; Tan T; Qi G; Li L; Wang M
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102063. PubMed ID: 36494073
[TBL] [Abstract][Full Text] [Related]
13. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?
Younossi ZM; Paik JM; Al Shabeeb R; Golabi P; Younossi I; Henry L
Hepatology; 2022 Nov; 76(5):1423-1437. PubMed ID: 35363908
[TBL] [Abstract][Full Text] [Related]
14. Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.
Sung KC; Yoo TK; Lee MY; Byrne CD; Zheng MH; Targher G
Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):482-491. PubMed ID: 36727522
[TBL] [Abstract][Full Text] [Related]
15. Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S.
Heredia NI; Zhang X; Balakrishnan M; Hwang JP; Thrift AP
Ethn Health; 2023 Feb; 28(2):299-312. PubMed ID: 35067116
[TBL] [Abstract][Full Text] [Related]
16. Different minimal alcohol consumption in male and female individuals with metabolic dysfunction-associated fatty liver disease.
Zhu Y; Xu X; Fan Z; Ma X; Rui F; Ni W; Hu X; Gu Q; Shi J; Wu C; Yeo YH; Li J
Liver Int; 2024 Mar; 44(3):865-875. PubMed ID: 38263792
[TBL] [Abstract][Full Text] [Related]
17. Association of aspirin with all-cause and cardiocerebrovascular mortality in patients with metabolic associated fatty liver disease.
Chen Z; Chen M; Zeng P; Yang X; Li Q
Scand J Gastroenterol; 2023; 58(8):908-914. PubMed ID: 36799202
[TBL] [Abstract][Full Text] [Related]
18. Liver biomarkers, genetic and lifestyle risk factors in relation to risk of cardiovascular disease in Chinese.
Wang X; Cheng S; Lv J; Yu C; Guo Y; Pei P; Yang L; Millwood IY; Walters R; Chen Y; Du H; Duan H; Gilbert S; Avery D; Chen J; Pang Y; Chen Z; Li L
Front Cardiovasc Med; 2022; 9():938902. PubMed ID: 36035906
[TBL] [Abstract][Full Text] [Related]
19. Metabolic associated fatty liver disease and sarcopenia additively increase mortality: a real-world study.
Zhao Q; Yin Y; Deng Y
Nutr Diabetes; 2023 Nov; 13(1):21. PubMed ID: 37968264
[TBL] [Abstract][Full Text] [Related]
20. Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018.
Xie Z; Aimuzi R; Si M; Qu Y; Jiang Y
Front Public Health; 2023; 11():1133194. PubMed ID: 36950101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
